Plain-English translation of NCT07811518 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Phase
Post-approval monitoring
Sponsor
Affiliated Hospital of Nantong University
Collaborators
Meishan Municipal Center for Disease Prevention and Control
Enrollment target
~3,000 participants
Started
August 2022
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
14 Years – 24 Years
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gang Qin, MD, PhD
Affiliated Hospital of Nantong University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.